CPDD 78th Annual Scientific Meeting Program

Thursday, June 16, 2016
81 Acute inhibitory control training in cocaine users
J. L. Alcorn 2 , E. Pike 1,2 , J. A. Lile 1,2,3 , W. W. Stoops 1,2,3 , C. R. Rush 1,2,3 , 1 Psychology,
University of Kentucky, Lexington, KY, 2 Behavioral Science, University of Kentucky,
Lexington, KY, 3 Psychiatry, University of Kentucky, Lexington, KY
82 Effects of mixed amphetamine salts dose and belief about drug assignment on cognitive
performance in college students
K. Cropsey, M. Froelich, P. Hendricks, R. Fargason, University of Alabama at Birmingham,
Birmingham, AL
83 Cocaine decreases preference for condom use as function of delayed condom availability and
STI risk
M. W. Johnson 1 , E. S. Herrmann 2 , P. S. Johnson 3 , M. M. Sweeney 1 , 1 Psychiatry and
Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD,
2
New York State Psychiatric Institute, New York, NY, 3 Psychology, California State
University, Chico, Chico, CA
84 The influence of buspirone maintenance on the pharmacodynamic effects of methamphetamine
A. R. Reynolds 1 , W. W. Stoops 1,2,3 , J. A. Lile 1,2,3 , C. R. Rush 1,2,3 , 1 Behavioral Science,
University of Kentucky, Lexington, KY, 2 Psychology, University of Kentucky,
Lexington, KY, 3 Psychiatry, University of Kentucky, Lexington, KY
85 Impact of lisdexamfetamine on retention of methamphetamine-dependent patients in a
residential facility
M. J. Mancino 2 , J. D. Thostenson 3 , J. B. Guise 2 , J. McGaugh 2 , A. Oliveto 2 , 2 Psychiatry,
University of Arkansas for Medical Sciences, Little Rock, AR, 3 Biostatistics, University of
Arkansas for Medical Sciences, Little Rock, AR
86 Cue-induced cocaine craving increases with aripiprazole treatment in methadone-maintenance
patients
L. Moran 1 , K. A. Phillips 1 , W. J. Kowalczyk 1 , U. Ghitza 2 , D. H. Epstein 1 , K. L. Preston 1 ,
1
NIDA-IRP, Baltimore, MD, 2 NIDA, Baltimore, MD
87 A novel approach to naltrexone injections may reduce complications and increase adherence
J. Walker 1 , D. Santos 3 , C. Rowe 1 , G. Santos 1,2 , S. Jung 1 , P. Coffin 1,4 , 1 Substance Use Research
Unit, San Francisco Department of Public Health, San Francisco, CA, 2 Community Health
Systems, University of California San Francisco, San Francisco, CA, 3 Housing and Urban
Health, San Francisco Department of Public Health, San Francisco, CA, 4 Division of HIV/
AIDS, University of California, San Francisco, San Francisco, CA
88 Changes in quality of life in cocaine-dependent participants provided treatment with
buprenorphine and naloxone and extended-release naltrexone
D. Blumberg 1 , F. Carrizales 2 , W. Kazanis 2 , M. P. Hillhouse 3 , A. G. Matthews 4 , J. S. Potter 2 ,
1
NIDA Clinical Coordinating Center, The Emmes Corporation, Rockville, MD, 2 Psychiatry,
UT Health Science Center, San Antonio, TX, 3 Integrated Substance Abuse Programs,
University of California, Los Angeles, CA, 4 The Emmes Corporation, Rockville, MD
89 Participant treatment assignment perceptions in the NIDA CTN cocaine use reduction with
buprenorphine study
A. G. Matthews 2 , M. P. Hillhouse 1 , C. Thomas 1 , W. Ling 1 , D. Blumberg 2 , 1 UCLA, Los
Angeles, CA, 2 Emmes, Rockville, MD
90 Use of contingency management for crack cocaine dependence in South America: Preliminary
results from a randomized clinical trial
A. Q. Miguel 1 , C. S. Madruga 2 , S. McPherson 3 , M. G. McDonell 3 , J. M. Roll 3 , R. Laranjeira 2 ,
1
Psychiatry, Federal University of São Paulo, Sao Paulo, Brazil, 2 Psychiatry, Universidade
Federal de São Paulo, Sao Paulo, Brazil, 3 Washington State University, Spokane, WA
99